| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
149,418 |
293,719 |
402,743 |
782,338 |
| Total Sell Value |
$57,642,236 |
$111,244,170 |
$144,625,015 |
$240,103,649 |
| Total People Sold |
7 |
10 |
12 |
12 |
| Total Sell Transactions |
22 |
33 |
44 |
71 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Levy Alan J |
Director |
– • – |
2022-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
555 |
24,837 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2022-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
555 |
15,000 |
|
- |
|
| Reed Monica P |
Director |
– • – |
2022-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
555 |
555 |
|
- |
|
| Barratt Craig H |
Director |
– • – |
2022-04-22 |
4 |
OE |
$0.00 |
$0 |
I/I |
753 |
24,696 |
|
- |
|
| Ladd Amy L |
Director |
– • – |
2022-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
555 |
1,320 |
|
- |
|
| Berry Joseph C |
Director |
– • – |
2022-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
555 |
1,320 |
|
- |
|
| Leonard Keith R |
Director |
– • – |
2022-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
555 |
3,102 |
|
- |
|
| Johnson Amal M |
Director |
– • – |
2022-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
555 |
11,224 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2022-03-01 |
4 |
AS |
$289.96 |
$579,920 |
D/D |
(2,000) |
361 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2022-02-28 |
4 |
D |
$290.33 |
$324,879 |
D/D |
(1,119) |
2,361 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,256 |
3,480 |
|
- |
|
| Rosa David J. |
Executive Vice President and C |
• – – |
2022-02-28 |
4 |
D |
$290.33 |
$324,879 |
D/D |
(1,119) |
116,942 |
|
- |
|
| Rosa David J. |
Executive Vice President and C |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,256 |
118,061 |
|
- |
|
| Widman Fredrik |
VP Corporate Controller |
• – – |
2022-02-28 |
4 |
D |
$290.33 |
$85,647 |
D/D |
(295) |
2,686 |
|
- |
|
| Widman Fredrik |
VP Corporate Controller |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
852 |
2,981 |
|
- |
|
| Desantis Robert |
EVP & Chief Product Officer |
• – – |
2022-02-28 |
4 |
D |
$290.33 |
$292,653 |
D/D |
(1,008) |
6,355 |
|
- |
|
| Desantis Robert |
EVP & Chief Product Officer |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,175 |
7,363 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2022-02-28 |
4 |
D |
$290.33 |
$162,585 |
D/D |
(560) |
18,067 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,128 |
18,627 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2022-02-28 |
4 |
D |
$290.33 |
$556,853 |
D/D |
(1,918) |
8,019 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,867 |
9,937 |
|
- |
|
| Charlton Henry L |
Senior Vice President & Chief |
• – – |
2022-02-28 |
4 |
D |
$290.33 |
$189,876 |
D/D |
(654) |
17,154 |
|
- |
|
| Charlton Henry L |
Senior Vice President & Chief |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,449 |
17,808 |
|
- |
|
| Samath Jamie |
Chief Financial Officer |
• – – |
2022-02-28 |
4 |
D |
$290.33 |
$156,488 |
D/D |
(539) |
3,415 |
|
- |
|
| Samath Jamie |
Chief Financial Officer |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,257 |
3,954 |
|
- |
|
1324 Records found
|
|
Page 11 of 53 |
|
|
5.92 (1.56%) 
